CHARLES POWELL: Open Payments
NPI 1477013381 · LENOIR CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 34 payments from 15 companies in 2025. Trend: 2023 $928 · 2024 $1,135 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $89 |
| Novo Nordisk Inc | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| PFIZER INC. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Janssen Biotech, Inc. | 2 | $45 |
| Amgen Inc. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $30 |
Products named: Dexcom G6 Transmitter, Wegovy, REXULTI, ELIQUIS, AIRSUPRA, ERLEADA, CAPLYTA, OTEZLA.
Industry payments across TN — which companies pay providers there.
